RES EAR CH A RT I C LE Open Access MERS transmission and risk factors : a systematic review Ji - Eun Park 1 , Soyoung Jung 2 , Aeran Kim 2 and Ji - Eun Park 3 , 4 * Abstract Background : Since Middle East respiratory syndrome ( MERS ) infection was first reported in 2012 , many studies have analysed its transmissibility and severity . However , the methodology and results of these studies have varied , and there has been no systematic review of MERS . This study reviews the characteristics and associated risk factors of MERS . Method : We searched international ( PubMed , ScienceDirect , Cochrane ) and Korean databases ( DBpia , KISS ) for English - or Korean - language articles using the terms “ MERS ” and “ Middle East respiratory syndrome ” . Only human studies with > 20 participants were analysed to exclude studies with low representation . Epidemiologic studies with information on transmissibility and severity of MERS as well as studies containing MERS risk factors were included . Result : A total of 59 studies were included . Most studies from Saudi Arabia reported higher mortality ( 22 – 69 . 2 % ) than those from South Korea ( 20 . 4 % ) . While the R 0 value in Saudi Arabia was < 1 in all but one study , in South Korea , the R 0 value was 2 . 5 – 8 . 09 in the early stage and decreased to < 1 in the later stage . The incubation period was 4 . 5 – 5 . 2 days in Saudi Arabia and 6 – 7 . 8 days in South Korea . Duration from onset was 4 – 10 days to confirmation , 2 . 9 – 5 . 3 days to hospitalization , 11 – 17 days to death , and 14 – 20 days to discharge . Older age and concomitant disease were the most common factors related to MERS infection , severity , and mortality . Conclusion : The transmissibility and severity of MERS differed by outbreak region and patient characteristics . Further studies assessing the risk of MERS should consider these factors . Keywords : MERS , Middle East respiratory syndrome , Infectivity , Severity , Mortality Background Middle East respiratory syndrome ( MERS ) was first reported in 2012 in Saudi Arabia [ 1 ] . Although most patients are linked to the Arabian Peninsula geographic - ally , MERS has been detected in many other parts of the world [ 2 ] . A large MERS cluster was also observed in 2015 in South Korea [ 3 ] . MERS causes sporadic infection and intrafamilial and healthcare - associated infection . Its symptoms can vary from asymptomatic infection to death . Despite the infec - tion ’ s association with high mortality , specified antiviral therapy is lacking , especially for patients with concomi - tant diseases [ 2 ] . Many previous studies have assessed the risks of MERS , such as factors dictating severity or an infection risk , yet the indices they present vary . For example , the case fatality rate was found to be 25 . 9 % in the Middle East area , but 20 . 4 % in South Korea [ 4 ] . The incubation period was reported to be 6 . 83 – 7 days in South Korea [ 4 , 5 ] , but 5 . 5 in a study using data from multiple areas [ 6 ] and 5 . 2 in Saudi Arabia [ 7 ] . Accurate assessment of the risk of MERS is essential for predicting and prevent - ing infection . A systematic review of the risk of MERS , as covered in previous studies , is potentially helpful for predicting this spread , and its future impact . This study aimed at reviewing the risk of MERS , focusing on indices related to infectivity and severity . * Correspondence : jepark @ kiom . re . kr 3 Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , Republic of Korea 4 Center for Convergent Research of Emerging Virus Infection , Korea Research Institute of Chemical Technology , Daejeon , Republic of Korea Full list of author information is available at the end of the article © The Author ( s ) . 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4 . 0 International License ( http : / / creativecommons . org / licenses / by / 4 . 0 / ) , which permits unrestricted use , distribution , and reproduction in any medium , provided you give appropriate credit to the original author ( s ) and the source , provide a link to the Creative Commons license , and indicate if changes were made . The Creative Commons Public Domain Dedication waiver ( http : / / creativecommons . org / publicdomain / zero / 1 . 0 / ) applies to the data made available in this article , unless otherwise stated . Park et al . BMC Public Health ( 2018 ) 18 : 574 https : / / doi . org / 10 . 1186 / s12889 - 018 - 5484 - 8 Methods We searched international ( PubMed , ScienceDirect , Cochrane ) and Korean databases ( DBpia , KISS ) using the term “ MERS ” or “ Middle East respiratory syn - drome ” , encompassing articles published after 2000 . The search process was conducted in October 2017 . We also manually searched the reference lists of the included studies . Human studies were included , while animal studies and reviews were excluded . Only articles in English or Korean were included . Even if a study collected data on humans , such as collecting specimens from religious pil - grims , it was excluded if there were no MERS patients in the study sample . Additionally , case studies including fewer than 20 MERS patients were excluded as they were considered as having insufficient MERS patient numbers and representative information . The included studies were classified as epidemiologic studies and those covering risk factors of MERS . In the epidemiologic category , indices related to the risk of MERS were divided into two categories ; related to in - fectivity and related to severity . The index related to in - fectivity included the reproduction number ( R ) , attack rate , incubation period , serial interval , and days from on - set to confirmation . The index related to severity in - cluded the case fatality rate ( CFR ) , days from onset to hospitalization , days from onset to discharge , days from onset to death , and days from hospitalization to death . In the risk factor category , factors related to infection , transmission , severity , and mortality of MERS were ana - lysed . Even if the included studies investigated factors that were related to mortality , when they did not analyse risk factors of severity or mortality using appropriate statistical methods ( e . g . , regression analysis , Cox propor - tional hazards model ) or only compared prevalence fac - tors , we excluded them from the risk factor category . In all categories , we extracted the study period , number of participants , and geographical region where the data were collected using a data extraction form confirmed after pilot assessment . Results A total of 3009 studies were searched , and 2717 were reviewed , excluding 292 duplicate studies . After the title and abstract review , a further 1804 and 663 were ex - cluded , respectively . Another four studies were included via a manual search , which left a total of 58 studies for analysis ( Fig . 1 ) . Epidemiologic studies The 38 of total 58 included studies were classified as ep - idemiologic studies ( Table 1 ) . R value R value , representing the reproduction number , indicates the average number of secondary cases generated by in - fectious individuals . Thirteen studies reported R value of MERS . Four studies that used data from multiple areas had R < 1 . 0 [ 6 , 8 – 10 ] . Studies using Saudi Arabia or Middle East area data reported R < 1 , at 0 . 45 – 0 . 98 [ 11 – 14 ] , though one reported 1 . 9 – 3 . 9 [ 15 ] . Studies using South Korea data showed higher values , at 2 . 5 – 8 . 09 [ 16 – 19 ] , in the early stage , and < 1 in the later period [ 20 ] or with control intervention [ 19 ] . Attack rate A total of eight studies reported the attack rate . Four re - ported the overall or secondary attack rate , and the other four reported the attack rate of specific participant groups . Two studies conducted in Saudi Arabia showed 0 . 42 % [ 21 ] and 4 % [ 22 ] secondary attack rates . Studies in South Korea showed secondary attack rates of 3 . 7 % in one study [ 23 ] and 14 . 3 – 15 . 8 % in another [ 24 ] . Two studies reported the attack rate among healthcare workers ( HCWs ) . One study in South Korea reported a MERS incidence of 1 . 5 % among HCWs [ 20 ] , and another study using multiple area data reported a 13 . 4 – 13 . 5 % in - fection rate among HCWs [ 8 ] . The attack rate among hos - pital patients was 4 % in one study [ 5 ] and 22 % in the early and 1 % in the later period in another [ 16 ] . Incubation period The incubation period is the period between infection and appearance of signs of a disease . A total of 12 studies re - ported the incubation period of MERS . Nine used data from South Korea and showed a 6 – 7 . 8 day incubation period [ 3 – 5 , 23 – 28 ] . One study using data from Saudi Arabia reported a 5 . 2 day incubation period [ 7 ] , and an - other using data from multiple areas reported a 5 . 5 day in - cubation period [ 6 ] . Sha et al . compared the incubation periods between the Middle East area and South Korea and reported 4 . 5 – 5 and 6 days , respectively [ 29 ] . Serial interval The serial interval of an infectious disease represents the duration between symptom onset of a primary case and of its secondary cases . Two studies used South Korea data , reporting serial intervals of MERS of 12 . 6 and 14 . 6 days , respectively [ 24 , 26 ] . Days from onset to confirmation Among five studies reporting days from onset to con - firmation , three studies used data from South Korea . One study analysing all South Korea cases reported 5 days from onset to confirmation [ 3 ] . Park et al . re - ported 6 . 5 days for all cases , 9 for second generation and 4 for third generation [ 28 ] . One study from Taiwan Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 2 of 15 reported 6 days for HCWs and 10 for non - HCWs [ 30 ] . A study from Saudi Arabia reported 4 days from onset to confirmation [ 31 ] . Sha et al . compared the data from Middle East and South Korea areas and reported 4 – 8 and 4 – 5 days , respectively [ 29 ] . Days from onset to hospitalization Two studies from Saudi Arabia reported days from onset to hospitalization . One reported 2 . 9 – 5 days [ 32 ] , and the other reported 5 . 3 days [ 33 ] . Mortality Twenty - six studies reported on MERS - related mortality . Ten reported the mortality rate in South Korea as 14 . 5 – 47 . 8 % [ 3 , 4 , 23 – 26 , 28 , 29 , 34 , 35 ] ; one of which , includ - ing all MERS patients in South Korea , reported a mor - tality rate of 20 . 4 % [ 27 ] . Ten studies analysing data from Saudi Arabia reported higher mortality rates , of 22 – 69 . 2 % [ 7 , 12 , 22 , 31 – 33 , 36 – 39 ] , although others reported mortality rates 10 % [ 40 ] and 19 . 9 % [ 21 ] . A Taiwanese study reported a mortality rate of 35 . 6 % [ 30 ] . Studies using data from multiple areas reported mortality rates ranging from 26 . 6 % [ 29 ] to 59 . 4 % [ 9 , 41 ] . Days from onset to discharge Three studies reported days from MERS onset to dis - charge . Sha et al . reported 14 days in the Middle East area and 17 in South Korea [ 29 ] . One study from Saudi Arabia reported 17 days [ 36 ] , and another in South Korea reported 20 [ 3 ] . Days from onset to death Two Korean studies reported similar periods of 11 – 13 days from onset to death : 11 – 12 . 5 in Park et al . [ 24 ] and 13 in Ki et al . [ 3 ] . Although one study from Saudi Arabia reported longer than 17 days from onset to death [ 36 ] , Sha et al . , comparing data between the Middle East and South Korea , reported similar periods of 11 . 5 and 11 days , respectively [ 29 ] . One Taiwanese study also re - ported a similar period of 12 – 13 days [ 30 ] . Fig . 1 Flow of the systematic review in this study Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 3 of 15 T a b l e 1 E p i d e m i o l o g i c s t u d i e s o f M E R S , 2012 – 2017 A u t ho r ( y e a r ) C o u n t r y S t u d y p e r i o d N o . o f p a t i e n t s ( M / F ) A g e o f p a t i e n t s F a t a li t y r a t e C on t a c t / c o m o r b i d i t y I n d e x r e l a t e d t o i n f e c t i v i t y I n d e x r e l a t e d t o s e v e r i t y A h m e d ( 2017 ) [ 31 ] S a u d i A r a b i a 2015 – 2017 537 ( 370 / 167 ) 55 ± 17 . 9 218 / 537 ( 40 . 6 % ) (cid:129) C o m o r b i d i t y : 73 . 9 % (cid:129) C on t a c t s - H o s p i t a l - a c q u i r e d : 38 . 7 % - H o u s e ho l d : 9 . 9 % - C a m e l : 25 . 3 % - U n k no w n : 26 . 1 % (cid:129) O n s e t t o c on f i r m a t i on : 4 d a y s ( I Q R : 2 – 7 d a y s ) A l e n a z i ( 2017 ) [ 12 ] S a u d i A r a b i a 2015 130 ( 66 / 64 ) 63 . 5 ( c o mm u n i t y - a c q u i r e d ) , 64 . 7 ( h e a l t h c a r e - a c q u i r e d ) , 40 . 1 ( H C W ) 51 / 130 ( 39 . 2 % ) (cid:129) C on t a c t s - C o mm u n i t y - a c q u i r e d : 20 % - H e a l t h c a r e - a c q u i r e d : 46 . 9 % - H C W s : 33 . 1 % (cid:129) R - H o s p i t a l - a c q u i r e d : 0 . 98 f o r 2 n d , 0 . 64 f o r 3 r d , 0 . 23 f o r 4 t h g e n e r a t i on E l - B u s h r a ( 2017 ) [ 2 1 ] S a u d i A r a b i a 2015 87 n . r . n . r . (cid:129) C on t a c t s - 20 p r i m a r y , 39 f i r s t , 18 s , 7 t h i r d , 3 f o u r t h g e n e r a t i on (cid:129) S e c on d a r y a tt a c k r a t e / 10 , 000 : 42 ( 95 % C I : 33 – 54 ) K i m ( 2017 ) S o u t h K o r e a 2015 186 ( 111 / 75 ) 55 38 / 186 ( 19 . 9 % ) (cid:129) C on t a c t s - H o s p i t a l ( 99 . 4 % ) - H o u s e ho l d ( 0 . 6 % ) - C o mm u n i t y ( 0 % ) (cid:129) C o m o r b i d i t y - 29 / 38 f a t a li t i e s h a d u n d e r l y i n g d i s e a s e P a r k ( 2017 ) [ 23 ] S o u t h K o r e a 2015 25 ( 13 / 12 ) 71 a ( I Q R : 38 – 86 ) 25 / 11 ( 44 . 0 % ) (cid:129) A tt a c k r a t e : 3 . 7 % (cid:129) I n c u b a t i on p e r i o d : 6 . 1 d a y s S h a ( 2017 ) [ 29 ] M i dd l e E a s t a r e a / S o u t h K o r e a 2012 – 2016 683 ( 423 / 260 ) 50 – 60 ( f a t a l ) , 38 – 46 ( non - f a t a l ) 182 ( 26 . 6 % ) ( M i dd l e E a s t : 25 . 9 % , S o u t h K o r e a : 13 . 8 % ) (cid:129) C o m o r b i d i t y - 67 . 9 % i n f a t a l , 22 . 2 % i n non f a t a l c a s e s (cid:129) I n c u b a t i on p e r i o d - 4 . 5 – 5 d a y s i n M i dd l e E a s t a r e a - 6 d a y s i n S o u t h K o r e a (cid:129) O n s e t t o c on f i r m a t i on - 8 d a y s i n f a t a l , 4 d a y s i n non f a t a l i n M i dd l e E a s t a r e a - 4 d a y s i n f a t a l , 5 d a y s non f a t a l i n S o u t h K o r e a (cid:129) O n s e t t o d e a t h - 11 . 5 d a y s i n M i dd l e E a s t a r e a - 11 d a y s i n S o u t h K o r e a (cid:129) O n s e t t o d i s c h a r g e - 14 d a y s i n M i dd l e E a s t a r e a - 17 d a y s i n S o u t h K o r e a S h e r b i n i ( 2017 ) [ 32 ] S a u d i A r a b i a 2014 29 ( 20 / 9 ) 45 ± 12 10 ( 34 % ) (cid:129) C o m o r b i d i t i e s - D i a b e t e s ( 31 % ) - C h r on i c k i d n e y d i s e a s e ( 27 % ) (cid:129) S y m p t o m s t o ho s p i t a li z a t i on : 2 . 9 – 5 d a y s A ss i r i ( 2016 ) [ 36 ] S a u d i A r a b i a 2014 – 2015 38 ( 28 / 10 ) 51 ( r a n g e 17 – 84 ) 21 / 38 ( 55 . 3 % ) (cid:129) C on t a c t s - 13 H C W s - 15 w e r e a ss o c i a t e d w i t h 1 d i a l y s i s u n i t (cid:129) O n s e t t o d e a t h / d i s c h a r g e : 17 d a y s ( r a n g e 1 . 0 – 84 . 0 ) Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 4 of 15 T a b l e 1 E p i d e m i o l o g i c s t u d i e s o f M E R S , 2012 – 2017 ( C o n t i n u e d ) C ho ( 2016 ) [ 5 ] S o u t h K o r e a 2015 82 ( 53 / 29 ) 57 ( p a t i e n t s a n d v i s i t o r s ) , 38 ( H C W ) n . r . (cid:129) C on t a c t s - P a t i e n t s : 40 . 2 % - V i s i t o r s : 50 % - H C W s : 9 . 8 % (cid:129) C o m o r b i d i t y - 24 ( 29 % ) h a d u n d e r l y i n g d i s e a s e (cid:129) I n c u b a t i on p e r i o d : 7 d a y s ( r a n g e : 2 – 17 , I Q R : 5 – 10 ) (cid:129) O v e r a ll a tt a c k r a t e - P a t i e n t s i n t h e e m e r g e n cy r o o m : 4 % ( 30 / 675 ) - V i s i t o r s : 6 % ( 38 / 683 ) H a li m ( 2016 ) [ 33 ] S a u d i A r a b i a 2016 32 ( 20 / 12 ) 43 . 99 ± 13 . 03 14 / 32 ( 43 . 8 % ) (cid:129) F r o m s y m p t o m t o ho s p i t a li z a t i on - 5 . 3 ± 3 . 3 d a y s (cid:129) T o t a l l e n g t h o f s t a y - 15 ± 3 . 6 d a y s L i u ( 2016 ) T a i w a n 2012 – 2015 1368 ( 883 / 476 ) a 49 ( r a n g e : 2 – 90 ) 35 . 6 % ( 487 / 1368 ) (cid:129) C F R 7 . 03 % f o r H C W - 36 . 96 % f o r non - H C W (cid:129) C on t a c t s - P a t i e n t s : 46 . 2 % - F a m il y m e m b e r s o r v i s i t o r s : 34 . 9 % - H C W : 18 . 9 % (cid:129) O n s e t t o d e a t h - 13 ( 4 – 17 ) d a y s f o r H C P - 12 ( 1 – 52 ) d a y s f o r non - H C W (cid:129) O n s e t t o c on f i r m a t i on - 6 ( 1 – 14 ) d a y s f o r H C P - 10 ( 1 – 21 ) d a y s f o r non - H C W M oh d ( 2016 ) [ 40 ] S a u d i A r a b i a 2014 – 2015 80 ( 48 / 32 ) 40 a (cid:129) 10 % ( 8 / 80 ) (cid:129) C o m o r b i d i t y - N o t d i ff e r e n t f r o m non - M E R S g r o u p s P a r k ( 2016 ) [ 24 ] S o u t h K o r e a 2015 23 ( 13 / 10 ) 66 a ( r a n g e : 31 – 87 ) i n ho s p i t a l A ; 74 . 5 a ( r a n g e : 60 – 82 ) i n ho s p i t a l B 11 / 23 ( 47 . 8 % ) (cid:129) G e n e r a t i on - 23 i n 2 n d ; 3 i n 3 r d (cid:129) I n c u b a t i on p e r i o d - 7 . 8 d a y s ( 95 % C I : 6 . 0 – 10 . 0 ) (cid:129) S e r i a l i n t e r va l - 1 4 . 6 d a y s ( 95 % C I , 12 . 9 – 16 . 5 ) (cid:129) S e c on d a r y a tt a c k r a t e - 15 . 8 % i n ho s p i t a l A - 14 . 3 % i n ho s p i t a l B (cid:129) T i m e t o d e a t h c - 12 . 5 d a y s ( I Q R : 5 . 5 – 19 ) i n ho s p i t a l A - 11 d a y s ( I Q R : 9 – 16 ) i n ho s p i t a l B V i r l o g e u x ( 2016 ) [ 2 5 ] S o u t h K o r e a 2015 170 ( 98 / 72 ) 54 . 6 ± 16 . 2 36 / 170 ( 21 % ) I n c u b a t i on p e r i o d : 6 . 9 d a y s ( 95 % C I : 6 . 3 – 7 . 5 ) C ho w e ll ( 2015 ) [ 8 ] S a u d i A r a b i a , S o u t h K o r e a 2013 – 2015 973 M E R S a n d 7634 S A R S c a s e s n . r . n . r . (cid:129) C on t a c t s - 43 . 5 – 100 % w e r e li n k e d t o h e a l t h c a r e s e tt i n g i n M E R S R 0 ( 95 % C I ) - M E R S : 0 . 91 ( 0 . 36 – 1 . 44 ) - S A R S : 0 . 95 ( 0 . 67 – 1 . 23 ) I n f e c t i on r a t e o f d i s e a s e a m on g H C W s : - M E R S : 13 . 4 – 13 . 5 % - S A R S : 18 . 8 – 57 . 1 % C o w li n g ( 2015 ) [ 26 ] S o u t h K o r e a 2015 166 ( 101 / 65 ) 55 . 4 ( r a n g e : 16 – 87 ) 24 / 166 ( 14 . 5 % ) (cid:129) C on t a c t s - 119 c a s e s h a d c on t a c t w i t h a c on f i r m e d c a s e - 30 / 166 ( 18 % ) w e r e h e a l t h c a r e p e r s onn e l (cid:129) I n c u b a t i on p e r i o d : 6 . 7 d a y s (cid:129) S e r i a l i n t e r va l : 12 . 6 d a y s . Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 5 of 15 T a b l e 1 E p i d e m i o l o g i c s t u d i e s o f M E R S , 2012 – 2017 ( C o n t i n u e d ) K C D C ( 2015 ) [ 4 ] S o u t h K o r e a 2015 186 ( 111 / 75 ) 55 a ( I Q R : 42 – 66 ) 36 / 186 ( 19 . 4 % ) (cid:129) C on t a c t s - 44 . 1 % p a t i e n t s e x p o s e d i n ho s p i t a l s - 32 . 8 % c a r e g i v e r s - 13 . 4 % H C W s (cid:129) C o m o r b i d i t i e s - 45 . 2 % (cid:129) I n c u b a t i on p e r i o d - 6 . 83 d a y s ( 95 % C I : 6 . 3 1 , 7 . 36 ) K i ( 2015 ) [ 3 ] S o u t h K o r e a 2015 186 ( 111 / 75 ) 50 s i n m e n a n d 60 s i n w o m e n 36 / 186 ( 19 . 4 % ) (cid:129) G e n e r a t i on - 28 i n 1 s t ( 15 . 1 % ) ; 125 i n 2 n d ( 67 . 2 % ) ; 32 i n 3 r d ( 17 . 2 % ) ; 2 w e r e no t c e r t a i n (cid:129) C on t a c t s - S a m e ho s p i t a l : 82 ( 44 % ) - F a m il y / h e a l t h c a r e a i d e s / v i s i t o r s : 71 ( 38 % ) - H C W s : 31 ( 17 % ) (cid:129) C o m o r b i d i t i e s - 77 ( 41 % ) h a d u n d e r l y i n g d i s e a s e s (cid:129) I n c u b a t i on p e r i o d : 6 . 5 d a y s ( 2 – 16 d a y s ) . (cid:129) F r o m s y m p t o m on s e t t o c on f i r m a t i on : 5 d a y s ( 0 – 17 d a y s ) (cid:129) F r o m s y m p t o m on s e t t o d i s c h a r g e f r o m t h e ho s p i t a l : 20 d a y s ( 8 – 41 d a y s ) . (cid:129) F r o m s y m p t o m on s e t t o d e a t h : 13 d a y s ( 1 – 41 d a y s ) M i n i s t r y o f H e a l t h , S o u t h K o r e a ( 2016 ) [ 27 ] S o u t h K o r e a 2015 186 ( 111 / 75 ) 50 s ( 21 . 6 % ) , 60 s ( 19 . 9 % ) 38 / 186 ( 20 . 4 % ) (cid:129) G e n e r a t i on - 28 i n 2 n d , 120 i n 3 r d , 26 i n 4 t h , 11 i n u n c l e a r / u n k no w n (cid:129) C on t a c t s - 82 p a t i e n t s i n ho s p i t a l - 63 f a m il y m e m b e r s / v i s i t o r s - 39 H C W s - 2 o t h e r s (cid:129) I n c u b a t i on p e r i o d - 6 . 83 d a y s ( 95 % C I : 6 . 3 1 – 7 . 36 ) N oo r w a li ( 2015 ) [ 3 7 ] S a u d i A r a b i a 2014 261 ( 171 / 90 ) n . r . 110 / 261 ( 42 % ) (cid:129) C on t a c t s - 84 H C W s - 177 non - H C W s P a r k ( 2015 ) [ 28 ] S o u t h K o r e a 2015 37 ( 21 / 16 ) 51 . 7 ( r a n g e : 24 – 79 ) 6 / 37 ( 16 . 2 % ) (cid:129) G e n e r a t i on - 1 i n 1 s t , 25 i n 2 n d , 11 i n 3 r d (cid:129) C on t a c t s - 20 p a t i e n t s - 12 r e l a t i v e s o f p a t i e n t s - 3 H C W s - 1 u n r e l a t e d v i s i t o r s (cid:129) C o m o r b i d i t i e s - 5 / 6 i n f a t a l , 3 / 31 i n non f a t a l I n c u b a t i on p e r i o d - 6 d a y s ( 95 % C I : 4 – 7 d a y s ) (cid:129) S y m p t o m on s e t t o c on f i r m a t i on - 6 . 5 d a y s ( 95 % C I : 4 – 9 ) f o r a ll c a s e s - 9 d a y s f o r s e c on d c a s e s - 4 d a y s f o r t h i r d c a s e s D r o s t e n ( 2014 ) [ 22 ] S a u d i A r a b i a 2013 26 ( 17 / 9 ) 55 a ( r a n g e : 2 – 83 ) 18 / 26 ( 69 . 2 % ) (cid:129) C on t a c t s - 280 ho u s e ho l d c on t a c t s (cid:129) S e c on d a r y t r a n s m i ss i on : 4 % A ss i r i ( 2013 ) [ 7 ] S a u d i A r a b i a 2012 – 2013 47 ( 36 / 11 ) n . r . 28 / 47 ( 60 % ) (cid:129) C o m o r b i d i t i e s (cid:129) I n c u b a t i on p e r i o d : 5 . 2 d a y s Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 6 of 15 T a b l e 1 E p i d e m i o l o g i c s t u d i e s o f M E R S , 2012 – 2017 ( C o n t i n u e d ) - 45 h a d u n d e r l y i n g c o m o r b i d m e d i c a l d i s o r d e r s ( 96 % ) B r e b a n ( 2013 ) [ 9 ] M u l t i p l e a r e a s 2012 – 2013 64 ( 44 / 17 ) b 56 a ( I Q R 41 – 68 . 5 ) 38 / 64 ( 59 . 4 % ) n . r . (cid:129) R 0 : 0 . 69 ( 95 % C I 0 . 5 0 – 0 . 92 ) O b oho ( 2012 ) [ 38 ] S a u d i A r a b i a 2014 255 ( 174 / 81 ) 45 a ( I Q R : 30 – 59 ) 93 ( 36 . 5 % ) (cid:129) C on t a c t s - 40 o f 191 s y m p t o m a t i c w e r e H C W s ( 20 . 9 % ) n . r . P e n tt i n e n ( 2013 ) [ 41 ] M u l t i p l e a r e a s 2012 – 2013 133 ( 51 / 77 ) b n . r . 45 % (cid:129) C on t a c t s - 14 p r i m a r y c a s e s , 129 c a s e s on t r a n s m i ss i on (cid:129) P r o p o r t i on t o I C U : 60 c a s e s ( 45 % ) E s t i m a t i n g t h e i n d e x o f i n f e c t i v i t y a n d s e v e r i t y u s i n g s e c on d a r y d a t a A u t ho r ( y e a r ) C o u n t r y S t u d y p e r i o d I n d e x e s r e l a t e d t o i n f e c t i v i t y I n d e x r e l a t e d t o s e v e r i t y C h a n g ( 2017 ) [ 18 ] S o u t h K o r e a 2015 (cid:129) R 0 - 8 . 097 C ho i ( 2017 ) [ 15 ] S o u t h K o r e a , S a u d i A r a b i a 2015 (cid:129) R 0 - 3 . 9 i n S o u t h K o r e a - 1 . 9 – 3 . 9 i n S a u d i A r a b i a ( 1 . 9 i n R i y a d h , 3 . 9 i n J e dd a h ) E i f a n ( 2017 ) [ 13 ] S a u d i A r a b i a 2013 – 2015 (cid:129) R - 0 . 85 – 0 . 97 Zh a n g ( 2017 ) [ 17 ] S o u t h K o r e a 2015 (cid:129) R - 2 . 5 – 7 . 2 K i m ( 2016 ) [ 16 ] S o u t h K o r e a 2015 (cid:129) R 0 - 5 . 4 ( 95 % C I : 4 . 61 – 6 . 19 ) i n p e r i o d 1 - 0 . 14 ( 95 % C I : 0 . 04 – 0 . 26 ) i n p e r i o d 2 (cid:129) I n f e c t i v i t y o f ho s p i t a li z e d p a t i e n t s - 22 ( 95 % C I : 18 . 73 – 25 . 27 ) i n p e r i o d 1 - 1 ( 95 % C I : 0 . 16 – 1 . 84 ) i n p e r i o d 2 L e s s l e r ( 2016 ) [ 39 ] S a u d i A r a b i a 2012 – 2014 (cid:129) C F R : 22 % ( 95 % C I : 18 , 25 ) K u c h a r s k i ( 2015 ) [ 1 0 ] M u l t i p l e a r e a s 2012 – 2013 (cid:129) R 0 : 0 . 47 ( 95 % C I : 0 . 29 – 0 . 80 ) M i z u m o t o ( 2015 ) [ 35 ] S o u t h K o r e a 2015 (cid:129) C F R : 20 . 0 % ( 95 % C I ) : 14 . 6 , 26 . 2 ) . X i a ( 2015 ) [ 19 ] S o u t h K o r e a 2015 (cid:129) R 0 Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 7 of 15 T a b l e 1 E p i d e m i o l o g i c s t u d i e s o f M E R S , 2012 – 2017 ( C o n t i n u e d ) - 4 . 422 i n e a r l y s t a g e - 0 . 385 w i t h c on t r o l f r o m ho s p i t a li z a t i on t o d e a t h : 15 . 16 ( 0 – 42 ) ( m e a n , r a n g e ) C a u c h e - m e z ( 2014 ) [ 6 ] M u l t i p l e a r e a s 2012 – 2013 (cid:129) I n c u b a t i on p e r i o d - 5 . 5 ( 95 % C I : 3 . 6 – 10 · 2 ) (cid:129) R 0 : 0 . 8 – 1 . 3 (cid:129) C F R - 74 % ( 95 % C I : 49 – 91 ) f o r f i r s t c a s e s - 21 % ( 95 % C I : 7 – 42 ) f o r s e c on d c a s e s C ho w e ll ( 2014 ) [ 11 ] S a u d i A r a b i a 2013 (cid:129) R o v e r a ll - 0 . 45 ( 95 % C I : 0 . 29 , 0 . 61 ) u n d e r t h e s u r v e ill a n c e - b i a s s c e n a r i o - 0 . 88 ( 95 % C I : 0 . 58 , 1 . 20 ) u n d e r t h e d i ff e r e n t i a l - t r a n s m i ss i b ili t y s c e n a r i o P o l e tt o ( 2014 ) [ 14 ] M i dd l e E a s t a r e a 2012 – 2013 (cid:129) R : 0 . 50 ( 95 % C I : 0 . 30 – 0 . 77 ) C I c o n f i d e n c e i n t e r va l , I C U i n t e n s i v e c a r e u n i t , I Q R i n t e r q u a rt il e r a ng e , H C W h e a l t h c a r e w o r k e r , S A R S s e v e r e a c u t e r e s p i r a t o r y s y n d r o m e a M e d i a n a g e , t h e o t h e r s a r e m e a n a g e b I n f o r m a t i o n o f s e v e r a l p a rt i c i p a n t s w a s m i ss i ng c D e f i n i t i o n i s n o t c l e a r i n t h i s s t u d y Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 8 of 15 Days from hospitalization to death Two studies reported a similar length of hospitalization : 15 [ 33 ] and 15 . 2 days [ 19 ] . Risk factors related to mortality Of the 20 studies included in the risk factor category , four were duplicates of studies in the epidemiologic cat - egory as they had information regarding the epidemio - logic index and risk factors ( Table 2 ) . Factors related to MERS infection Two studies reported on the risk factors of MERS infec - tion . Alraddadi et al . [ 42 ] analysed the effect of non - human contact , including travel history , animal - related exposure , food exposure , health condition , and behav - iour and reported direct dromedary exposure , diabetes or heart disease , and smoking as risk factors of MERS infection . Another study reported older age , outbreak week , and nationality as risk factors [ 43 ] . Factors related to MERS transmission Three studies analysed factors associated with spreaders . Non - isolated in - hospital days , hospitalization or emer - gency room visits before isolation , deceased patients , and clinical symptoms , including fever , chest X - ray ab - normality in more than three lung zones , and the cycle threshold value , were related to spreaders [ 34 , 44 , 45 ] . Factors related to MERS severity Four studies reported risk factors of MERS severity . The included studies showed that the PRNT 50 and CD4 T cell response [ 46 ] as well as a high MERS virus load [ 47 ] were associated with the severity of MERS . Additionally , male sex ; older age ; concomitant disease , including hypertension ; and symptoms , including fever , thrombocytopenia , lymphopenia , and low albumin con - centration , were related to MERS severity or secondary disease [ 47 – 49 ] . Factors related to MERS mortality Fifteen studies reported risk factors of mortality in MERS patients . Older age [ 4 , 25 , 32 , 49 – 55 ] and comor - bidity [ 29 , 50 – 52 , 54 ] , including diabetes [ 32 , 55 ] , chronic kidney disease [ 32 ] , respiratory disease [ 4 , 55 ] , pneumonia [ 56 ] , cardiac disease , and cancer [ 53 ] , were the most prevalent in the included studies . Male sex was reported as a risk factor in one study [ 56 ] . Smoking [ 32 , 56 ] and location of acquisition [ 51 , 53 ] were also re - ported . While one study noted that HCW , as a profes - sion , was associated with mortality [ 53 ] , non - HCWs were reported to be related to mortality in two other studies [ 50 , 51 ] . Additionally , a shorter incubation period [ 25 , 56 ] , lon - ger duration of symptoms [ 32 ] , more days from onset to confirmation [ 29 ] , later epidemic period [ 52 ] , and longer hospitalized days [ 29 ] were reported as mortality risk factors . Symptoms at diagnosis , including abnormal renal function [ 56 ] , respiratory symptoms [ 56 ] , gastrointestinal symptoms [ 32 ] , lower blood pressure [ 32 , 55 ] , and leuco - cytosis [ 55 , 56 ] , were also found to be associated with mortality in MERS patients . Severity of illness , [ 50 , 51 ] such as need for vasopres - sors [ 57 ] , chest radiographic score [ 58 ] , health condition [ 59 ] , use of mechanical ventilation [ 55 ] , and occurrence of dyspnoea [ 55 ] were also found to increase the mortal - ity risk . Epidemiological index of MERS between the Middle East area and South Korea The characteristics of MERS differ between South Korea and the Middle East area . The R value of MERS was re - ported to be below 1 in the Middle East area , except in one study [ 15 ] , but was from 2 . 5 – 8 . 1 in South Korea [ 15 – 19 ] . Although studies using data from the Middle East area reported 0 . 42 – 4 % secondary attack rates , stud - ies in South Korea reported 4 – 6 % secondary attack rates for patients or hospital visitors [ 5 ] , and 3 . 7 – 15 . 8 % for the overall attack rate [ 23 , 24 ] . The MERS incubation period was reported to be 4 . 5 – 5 . 2 days in the Middle East area [ 7 , 29 ] , but this period was found to be slightly longer in South Korea [ 3 – 5 , 23 – 28 ] . The severity of MERS also differed between the Mid - dle East area and South Korea . Mortality of MERS pa - tients was found to be 20 . 4 % in South Korea based on a report including all cases [ 27 ] , but most studies from Saudi Arabia reported higher rates , from 22 to 69 . 2 % [ 7 , 22 , 33 , 37 – 39 ] . Days from onset to confirmation were similar , 4 – 8 days in the Middle East area [ 29 , 31 ] and 4 – 6 . 5 days in South Korea [ 3 , 28 , 29 ] . Days from onset to discharge were slightly longer in South Korea , 14 – 17 days in the Middle East area [ 29 , 36 ] and 17 – 20 days in South Korea [ 3 , 29 ] ( Table 3 ) . Discussion The transmissibility and severity of MERS were different by outbreak countries , especially between the Middle East area and South Korea . The virus , host , and environ - mental factors may be the causes of the MERS outbreak - related differences between the two regions . From the standpoint of viral factors , there was a mutation of the MERS coronavirus ( MERS - CoV ) in the South Korea outbreak . Kim et al . [ 60 ] reported a point mutation in the receptor - binding domain of the viral spike protein in MERS - CoV , and another study showed that MERS - CoV in South Korea had higher genetic variability and muta - tion rates [ 61 ] . Individual characteristics can also affect MERS transmission . As previous studies showed , there Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 9 of 15 T a b l e 2 F a c t o r s r e l a t e d t o i n f e c t i on , t r a n s m i ss i on , s e v e r i t y , a n d m o r t a li t y o f M E R S A u t ho r ( y e a r ) S t u d y p e r i o d N o . o f p a r t i c i p a n t s ( T o t a l / d e a t h ) C o u n t r y P r e d i c t o r s S i g n i f i c a n t f a c t o r s R i s k f a c t o r s o f i n f e c t i o n A l r a dd a d i ( 2016 ) [ 42 ] 2014 146 ( 30 c a s e s , 1 16 c on t r o l s ) S a u d i A r a b i a T r av e l h i s t o r y , a n i m a l - r e l a t e d e x p o s u r e , f oo d e x p o s u r e , u n d e r l y i n g h e a l t h c on d i t i on s a n d b e h av i o r s D i r e c t d r o m e d a r y e x p o s u r e i n 2 w ee k s , c on c o m i t a n t w i t h d i a b e t e s o r h e a r t d i s e a s e , c u rr e n t l y s m o k i n g t o b a cc o H a s t i n g s ( 2016 ) [ 43 ] 2014 78 S a u d i A r a b i a N a t i on a li t y , s e x , a g e g r o u p , ho s p i t a l s e t t i n g , o u t b r e a k w ee k O l d e r a g e , o u t b r e a k w ee k , n a t i on a li t y R i s k f a c t o r s o f t r a n s m i ss i o n ( s p r e ad e r ) K a n g ( 2017 ) [ 44 ] 2015 186 S o u t h K o r e a A g e , s e x , c o m o r b i d i t y , s y m p t o m s , l a b o r a t o r y t e s t , c li n i c a l o u t c o m e , p h a s e i n t r a n s m i ss i on , i n c u b a t i on p e r i o d , s y m p t o m on s e t t o i s o l a t i on , non - i s o l a t e d i n - ho s p i t a l d a y s , s y m p t o m on s e t t o d i a g no s i s F e v e r , c h e s t X - r a y a b no r m a li t y i n > 3 l u n g z on e s , m o r e non - i s o l a t e d i n - ho s p i t a l d a y s K i m ( 2017 ) [ 34 ] 2015 186 S o u t h K o r e a U n d e r l y i n g r e s p i r a t o r y d i s e a s e , cyc l e t h r e s ho l d va l u e , s y m p t o m on s e t t o d i a g no s i s , no . o f c on t a c t s , ho s p i t a li z a t i on o r e m e r g e n cy r oo m b e f o r e i s o l a t i on L o w e r cyc l e t h r e s ho l d va l u e , ho s p i t a li z a t i on o r e m e r g e n cy r oo m v i s i t b e f o r e i s o l a t i on M a j u m d e r ( 2017 ) [ 45 ] 2015 186 S o u t h K o r e a S e x , a g e , c o m o r b i d i t y , c a s e c l a ss ( H C W , v i s i t o r , p a t i e n t ) , c a s e o u t c o m e ( r e c o v e r e d / d e c e a s e d ) D e c e a s e d c a s e o u t c o m e R i s k f a c t o r s o f s eve r i t y Zh a o ( 2017 ) [ 46 ] 2014 – 2015 21 S a u d i A r a b i a C D 4 T c e ll , C D 8 T c e ll , PR N T 50 H i g h e r PR N T 50 , h i g h e r C D 4 T c e ll r e s p on s e K o ( 2016 ) [ 48 ] 2015 45 S o u t h K o r e a D e m o g r a p h i c s ( a g e , s e x , B M I , u n d e r l y i n g d i s e a s e ) , s y m p t o m s ( f e v e r , m y a l g i a , c o u g h , s p u t u m , d i a rr h e a ) , l a b o r a t o r y t e s t ( w h i t e b l oo d c e ll , h e m o g l o b i n , t h r o m b o cy t o p e n i a , l y m p ho p e n i a , a l b u m i n , b ili r u b i n , a s p a r t a t e t r a n s a m i n a s e , a l a n i n e t r a n s a m i n a s e , b l o o d u r e a n i t r o g e n , c r e a t i n i n e , C - r e a c t i v e p r o t e i n , l a c t a t e d e h y d r o g e n a s e , t h r e s ho l d cyc l e va l u e o f P C R ) (cid:129) P n e u m on i a d e v e l o p m e n t : o l d e r a g e , f e v e r , t h r o m b o cy t o p e n i a , l y m p ho p e n i a , C - r e a c t i v e p r o t e i n ≥ 2 m g / d L , l o w e r t h r e s ho l d cyc l e va l u e o f P C R < 28 (cid:129) R e s p i r a t o r y f a il u r e : m a l e , h y p e r t e n s i on , l o w a l b u m i n c on c e n t r a t i on , t h r o m b o cy t o p e n i a , l y m p ho p e n i a , C - r e a c t i v e p r o t e i n F e i k i n ( 2015 ) [ 47 ] 2014 102 S a u d i A r a b i a A g e , s e x , u n d e r l y i n g ill n e ss , w ee k o f s p e c i m e n c o ll e c t i on , M E R S - C o V v i r u s l o a d (cid:129) S e v e r i t y : o l d e r a g e , u n d e r l y i n g ill n e ss , h i g h M E R S - C o V v i r u s l o a d (cid:129) M o r t a li t y : o l d e r a g e , u n d e r l y i n g ill n e ss , h i g h M E R S - C o V v i r u s l o a d S aa d ( 2014 ) [ 49 ] 2012 – 2014 70 S a u d i A r a b i a A g e , g e n d e r , o cc u p a t i on , a c q u i s i t i on o f i n f e c t i on , c o m o r b i d i t y , r a d i o l o g i c a l f i n d i n g s , c on c o m i t a n t i n f e c t i on s , l a b o r a t o r y a b no r m a li t i e s (cid:129) I C U c a r e : c on c o m i t a n t i n f e c t i on , d e c r e a s e d a l b u m i n (cid:129) M o r t a li t y : o l d e r a g e R i s k f a c t o r s o f m o r t a li t y A d e gb o y e ( 2017 ) [ 50 ] 2012 – 2015 959 / 317 ( 33 % ) S a u d i A r a b i a S e x , a g e , c o m o r b i d i t y , a n i m a l c on t a c t , c a m e l c on t a c t , H C W , s e c on d a r y c on t a c t , c li n i c a l e x p e r i e n c e O l d e r a g e , c o m o r b i d i t y , non - H C W , f a t a l c li n i c a l e x p e r i e n c e A h m e d ( 2017 ) [ 51 ] 2014 – 2016 660 / 197 ( 29 . 8 % ) S a u d i A r a b i a Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 10 of 15 T a b l e 2 F a c t o r s r e l a t e d t o i n f e c t i on , t r a n s m i ss i on , s e v e r i t y , a n d m o r t a li t y o f M E R S ( C o n t i n u e d ) A u t ho r ( y e a r ) S t u d y p e r i o d N o . o f p a r t i c i p a n t s ( T o t a l / d e a t h ) C o u n t r y P r e d i c t o r s S i g n i f i c a n t f a c t o r s A g e , s e x , n a t i on a li t y , s y m p t o m a t i c , H C W , s e v e r i t y , s o u r c e o f i n f e c t i on , r e g i on s (cid:129) 3 - d a y m o r t a li t y : o l d e r a g e , non - H C W , ho s p i t a l - a c q u i r e d i n f e c t i on (cid:129) 30 - d a y m o r t a li t y : o l d e r a g e , non - H C W , p r e - e x i s t i n g ill n e ss , s e v e r i t y , ho s p i t a l - a c q u i r e d i n f e c t i on S h a ( 2017 ) [ 29 ] 2012 – 2016 216 / 56 ( 25 . 9 % ) i n M i dd l e E a s t a r e a , 174 / 24 ( 13 . 8 % ) i n S o u t h K o r e a M i dd l e E a s t A r e a / S o u t h K o r e a A g e , s e x , e x p o s u r e t o c a m e l o r o t h e r a n i m a l s , c o m o r b i d i t y , d i s e a s e p r o g r e ss ( d a y s ) O l d e r a g e ( M i dd l e E a s t , S o u t h K o r e a ) , h i g h c o m o r b i d i t y ( M i dd l e E a s t , S o u t h K o r e a ) , l on g e r d a y s f r o m on s e t t o c on f i r m a t i on o f i n f e c t i on ( M i dd l e E a s t ) , l on g e r ho s p i t a li z e d d a y s ( M i dd l e E a s t ) S h e r b i n i ( 2017 ) [ 32 ] 2014 29 / 10 ( 34 . 5 % ) S a u d i A r a b i a S e x , s y m p t o m s , h i s t o r y o f c h r on i c d i s e a s e , d u r a t i on o f d i s e a s e b e f o r e ho s p i t a li z a t i o n , v i t a l s i g n s , t e m p e r a t u r e , b l oo d p r e ss u r e O l d e r a g e , g a s t r o i n t e s t i n a l s y m p t o m s , l on g e r d u r a t i on o f s y m p t o m s p r i o r t o ho s p i t a li z a t i on , d i a b e t e s m e lli t u s , c h r on i c k i d n e y d i s e a s e , s m o k e r s , l o w e r b l oo d p r e ss u r e N a m ( 2017 ) [ 56 ] 2015 25 / 11 ( 44 % ) S o u t h K o r e a - E p i d e m i o l o g i c ( a g e , s e x , ho s p i t a l , i n p a t i e n t , s t a y i n g i n t h e s a m e r oo m a s t h e i n d e x c a s e , s m o k i n g , p r ee x i s t i n g p n e u m on i a , c h r on i c l u n g d i s e a s e , i n c u b a t i on p e r i o d ) - C li n i c a l s y m p t o m - La b o r a t o r y e x a m i n a t i on s M a l e , p r e - e x i s t i n g p n e u m on i a , s m o k i n g h i s t o r y , i n c u b a t i on p e r i o d o f l e ss t h a n 5 d a y s , l e u k o cy t o s i s , a b no r m a l r e n a l f u n c t i on a t d i a g no s i s , r e s p i r a t o r y s y m p t o m s . Y a n g ( 2017 ) [ 52 ] 2012 – 2016 1743 / 559 ( 32 . 1 % ) M u l t i p l e a r e a A g e , s e x , c o m o r b i d i t y , e p i d e m i c p e r i o d , c on t a c t p a tt e r n , c o u n t r y O l d e r a g e , c o m o r b i d i t y , e p i d e m i c l a t e r p e r i o d A l m e k h l a f i ( 2016 ) [ 5 7 ] 2012 – 2014 31 / 23 ( 74 . 2 % ) S a u d i A r a b i a A g e , c o m o r b i d i t y , i n i t i a l m a n i f e s t a t i on s , p r o c e d u r e s ( non - i n va s i v e v e n t il a t i on , i n va s i v e v e n t il a t i on , c on t i n u o u s r e n a l r e p l a c e m e n t t h e r a p y ) , n ee d f o r va s o p r e ss o r N ee d f o r va s o p r e ss o r s A l s a h a f i ( 2016 ) [ 53 ] 2012 – 2015 924 / 425 ( 46 % ) S a u d i A r a b i a A g e , s e x , c o m o r b i d i t i e s , l o c a t i on o f a c q u i s i t i on ( ho u s e ho l d , i n p a t i e n t , H C W ) O l d e r a g e , c a r d i a c d i s e a s e , c a n c e r , ho u s e ho l d p a t i e n t s , H C W V i r l o g e u x ( 2016 ) [ 2 5 ] 2015 170 / 36 ( 21 % ) S o u t h K o r e a A g e , s e x , i n c u b a t i on p e r i o d O l d e r a g e , s ho r t e r i n c u b a t i on p e r i o d C h a ( 2015 ) 2015 30 / 5 ( 16 . 7 % ) S o u t h K o r e a A g e , s e x , c h r on i c k i d n e y d i s e a s e , d i a b e t e s , h y p e r t e n s i on , c o m o r b i d i t y , e s t i m a t e d g l o m e r u l a r f il t r a t i on r a t e , m e c h a n i c a l v e n t il a t o r N on e M a j u m d e r ( 2015 ) [ 54 ] 2015 159 / 35 ( 22 % ) S o u t h K o r e a F i v e p o t e n t i a l c o va r i a t e s w e r e a n a l y z e d : s e x , a g e , c on c u rr e n t h e a l t h c on d i t i on s t a t u s , h e a l t h c a r e w o r k e r s t a t u s , t i m e f r o m on s e t t o d i a g no s i s O l d e r a g e , p r e - e x i s t i n g c on c u rr e n t h e a l t h c on d i t i on s K C D C ( 2015 ) [ 4 ] 2015 186 / 36 ( 19 . 4 % ) S o u t h K o r e a S e x , a g e , c a s e c l a ss i f i c a t i on , r e s p i r a t o r y d i s e a s e , d i a b e t e s , c a r d i a c d i s e a s e , c h r on i c k i d n e y d i s e a s e , m a li g n a n cy O l d e r a g e , u n d e r l y i n g r e s p i r a t o r y d i s e a s e D a s ( 2015 ) [ 58 ] 2014 55 / 19 ( 35 % ) S a u d i A r a b i a A g e , c h e s t r a d i o g r a p h i c s c o r e , a b s o l u t e l y m p ho cy t e c o u n t , no . o f c o m o r b i d i t i e s , c on g e s t i v e h e a r t f a il u r e , h y p e r t e n s i on , d i a b e t e s C h e s t r a d i o g r a p h i c s c o r e Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 11 of 15 T a b l e 2 F a c t o r s r e l a t e d t o i n f e c t i on , t r a n s m i ss i on , s e v e r i t y , a n d m o r t a li t y o f M E R S ( C o n t i n u e d ) A u t ho r ( y e a r ) S t u d y p e r i o d N o . o f p a r t i c i p a n t s ( T o t a l / d e a t h ) C o u n t r y P r e d i c t o r s S i g n i f i c a n t f a c t o r s A l G h a m d i ( 2016 ) [ 5 9 ] 2014 51 / 19 ( 37 % ) S a u d i A r a b i a B e t a i n t e r f e r on , a l p h a i n t e r f e r on , h y d r o c o r t i s on e , R i b av i r i n , A P A C H E s c o r e A P A C H E s c o r e C ho i ( 2016 ) [ 55 ] 2016 186 / 33 ( 17 . 7 % ) S o u t h K o r e a A g e , s e x , H C W , c o e x i s t i n g m e d i c a l c on d i t i on , s y m p t o m s a t a d m i ss i on , v i t a l s i g n s a t a d m i ss i on , l a b o r a t o r y a b no r m a li t i e s a t a d m i ss i on , t r e a t m e n t A g e ≥ 55 y e a r s , o cc u rr e n c e o f d y s p n e a d u r i n g t h e d i s e a s e c o u r s e , p r e s e n c e o f c on c o m i t a n t m e d i c a l c on d i t i on s i n c l u d i n g d i a b e t e s o r c h r on i c l u n g d i s e a s e , s y s t o li c b l oo d p r e ss u r e < 90 mm H g a t a d m i ss i on , l e u k o cy t o s i s a t a d m i ss i on , u s e o f m e c h a n i c a l v e n t il a t i on A P A C H E a c u t e p h y s i o l o g i c a n d c h r o n i c h e a l t h e va l u a t i o n , I C D i n t e n s i v e c a r e u n i t , H C W h e a l t h c a r e w o r k e r , P C R p o l y m e r a s e c h a i n r e a c t i o n , P R N T p l a q u e r e d u c t i o n n e u tr a li z a t i o n t e s t Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 12 of 15 is an association between older age and MERS infec - tion [ 43 ] , severity [ 48 ] , and mortality [ 4 , 50 ] , and the population structure may be related to transmission and severity . Additionally , individuals aware of MERS were found to be more likely to practice preventive behaviour [ 62 ] , which differed by demographic char - acteristics [ 63 , 64 ] . The transmission environment may also contribute to the difference . While many MERS cases were contracted through exposure to camels in Saudi Arabia [ 42 ] , the South Korea out - break involved multiple generations of secondary infections caused by intra - hospital and hospital - to - hospital transmission [ 3 , 65 ] . Strategies considering various factors are therefore needed to assess the im - pact of MERS and to better control its spread . Although several studies have reported the overall R value [ 9 , 10 , 14 , 19 ] , others have shown that this value this can be variable based on the generation or a control intervention [ 11 , 16 , 19 ] . Especially in the South Korea epidemic , the R value was particularly high in the early stage or first generation , at 4 . 42 – 5 . 4 , though it later de - creased to 0 . 14 – 0 . 39 [ 16 , 19 ] . Further studies should consider and analyse the variation of the R value de - pending on the period or control intervention . While earlier studies on infectious diseases assumed a homogeneous infection ability of a population , recent studies have shown the existence of so - called super spreaders , individuals with a high potential to infect others in many infectious diseases , including Ebola and severe acute respiratory syndrome ( SARS ) [ 66 ] . The role of the super spreader is also important in the spread of MERS . In South Korea , 83 . 2 % of MERS patients were as - sociated with five super - spreading events [ 27 ] . Stein et al . [ 67 ] asserted that super spreaders were related with the host , pathogen , and environmental factors , and Wong et al . [ 66 ] reported that individual behaviours could also contribute to disease spread . There are variations in the mortality and attack rates among studies using South Korea data . For example , Park et al . [ 24 ] reported a 47 . 8 % MERS mortality , while reports from the Korean Ministry of Health and Welfare showed 20 . 4 % MERS mortality . This disparity may , in part , be due to small sample sizes . Park et al . [ 24 ] in - cluded only 23 patients because the study was conducted in an early phase of a MERS outbreak . We excluded studies that included cases with < 20 subjects , which were mostly case series , to reduce those types of biases . The present review found that older age and concomi - tant disease were risk factors of MERS infection and mortality . These results are consistent with a recent sys - tematic review that reported older age , male , and an underlying medical condition as predictors of death re - lated to MERS [ 68 ] ; therefore , these factors should be prioritized in protection and treatment procedures . One limitation of this study was the possibility of sub - ject duplication . Especially in South Korea , the Korean government publishes MERS reports that include all pa - tients . The epidemiologic index in other studies might be biased since they included partial Korean patients and were analysed in the middle of an outbreak . How - ever , we included those studies because they showed the characteristics of MERS in different situations and differ - ent stages . We did not conduct a meta - analysis because of the small number of studies for each index , which might be another limitation of this study . Although this study reviewed the risk factors of MERS and their impact , assessing the effect size of each risk factor is important . More studies investigating the effect of risk factors on MERS need to be constantly conducted . Conclusion Most studies on the transmissibility and severity of MERS have originated from Saudi Arabia and South Table 3 Epidemiologic index of MERS between the Middle East area and South Korea Index Saudi Arabia / Middle East area South Korea ( Study including all Korean cases ) Mortality 22 – 69 . 2 % ( Two of ten studies reported lower mortality than 20 % ) 14 . 5 – 47 . 8 % ( 20 . 4 % ) R - value 0 . 45 – 0 . 98 ( Only one study reported 1 . 9 – 3 . 9 ) (cid:129) 2 . 5 – 8 . 1 (cid:129) Less than 1 in later period or with control intervention Attack rate 0 . 42 – 4 % 3 . 7 – 15 . 8 % Incubation period 4 . 5 – 5 . 2 days 6 – 7 . 8 days ( 6 . 83 days ) Serial interval – 12 . 6 – 14 . 6 days Days from onset to confirmation 4 – 8 days 4 – 6 . 5 days ( 5 days ) Days from onset to hospitalization 2 . 9 – 5 . 3 days – Days from onset to discharge 14 – 17 days 17 – 20 days Days from onset to death 11 . 5 – 17 days 11 – 13 days Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 13 of 15 Korea . Even though the R 0 value in South Korea was higher than that in Saudi Arabia , mortality was higher in Saudi Arabia . The most common factors behind MERS infection and mortality were older age and concomitant disease . Future studies should consider the risk of MERS based on the outbreak region and patient characteristics . The results of the present study are valuable for inform - ing further studies and health policy in preparation for MERS outbreaks . Abbreviations CD4 : Cluster of differentiation 4 ; CFR : Case fatality rate ; MERS : Middle East respiratory syndrome ; PRNT : Plaque reduction neutralization test ; SARS : Severe acute respiratory syndrome Funding This work was supported by the National Research Council of Science & Technology ( NST ) grant by the Korea government ( MSIP ) ( No . CRC - 16 - 01 - KRICT ) and Korea Institute of Oriental Medicine ( G17273 ) . Authors ’ contributions JEP ( corresponding author ) designed the study , and conducted the data search and the analysis with JEP ( 1st author ) . SYJ and ARK participated in the data review . JEP ( corresponding ) drafted the manuscript , and JEP ( 1st ) , SYJ , and ARK revised it . All authors read and approved the final manuscript . Ethics approval and consent to participate Not applicable . Competing interests The authors declare that they have no competing interests . Publisher ’ s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations . Author details 1 Research Center for Korean Medicine Policy , Korea Institute of Oriental Medicine , Daejeon , Republic of Korea . 2 Clinical Research Division , Korea Institute of Oriental Medicine , Daejeon , Republic of Korea . 3 Herbal Medicine Research Division , Korea Institute of Oriental Medicine , Daejeon , Republic of Korea . 4 Center for Convergent Research of Emerging Virus Infection , Korea Research Institute of Chemical Technology , Daejeon , Republic of Korea . Received : 21 November 2017 Accepted : 19 April 2018 References 1 . Zaki AM , van Boheemen S , Bestebroer TM , Osterhaus AD , Fouchier RA . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia . N Engl J Med . 2012 ; 367 ( 19 ) : 1814 – 20 . 2 . World Health Organization ; WHO MERS - CoV global summary and risk assessment . 2016 . http : / / www . who . int / emergencies / mers - cov / mers - summary - 2016 . pdf ? ua = 1 & ua = 1 . Accessed 20 Oct 2017 . 3 . Ki M . 2015 MERS outbreak in Korea : hospital - to - hospital transmission . Epidemiol Health . 2015 ; https : / / doi . org / 10 . 4178 / epih / e2015033 . 4 . Korea Centers for Disease Control & Prevention . Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea , 2015 . Osong Public Health Res Perspect . 2015 ; 6 ( 4 ) : 269 – 78 . 5 . Cho SY , Kang JM , Ha YE , Park GE , Lee JY , Ko JH , et al . MERS - CoV outbreak following a single patient exposure in an emergency room in South Korea : an epidemiological outbreak study . Lancet . 2016 ; 388 ( 10048 ) : 994 – 1001 . 6 . Cauchemez S , Fraser C , Van Kerkhove MD , Donnelly CA , Riley S , Rambaut A , et al . Middle East respiratory syndrome coronavirus : quantification of the extent of the epidemic , surveillance biases , and transmissibility . Lancet Infect Dis . 2014 ; 14 ( 1 ) : 50 – 6 . 7 . Assiri A , Al - Tawfiq JA , Al - Rabeeah AA , Al - Rabiah FA , Al - Hajjar S , Al - Barrak A , et al . Epidemiological , demographic , and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia : a descriptive study . Lancet Infect Dis . 2013 ; 13 ( 9 ) : 752 – 61 . 8 . Chowell G , Abdirizak F , Lee S , Lee J , Jung E , Nishiura H , et al . Transmission characteristics of MERS and SARS in the healthcare setting : a comparative study . BMC Med . 2015 ; 13 : 210 . 9 . Breban R , Riou J , Fontanet A . Interhuman transmissibility of Middle East respiratory syndrome coronavirus : estimation of pandemic risk . Lancet . 2013 ; 382 ( 9893 ) : 694 – 9 . 10 . Kucharski AJ , Althaus CL . The role of superspreading in Middle East respiratory syndrome coronavirus ( MERS - CoV ) transmission . Euro Surveill . 2015 ; 20 ( 25 ) : 14 – 8 . 11 . Chowell G , Blumberg S , Simonsen L , Miller MA , Viboud C . Synthesizing data and models for the spread of MERS - CoV , 2013 : key role of index cases and hospital transmission . Epidemics . 2014 ; 9 : 40 – 51 . 12 . Alenazi TH , Al Arbash H , El - Saed A , Alshamrani MM , Baffoe - Bonnie H , Arabi YM , et al . Identified transmission dynamics of Middle East respiratory syndrome coronavirus infection during an outbreak : implications of an overcrowded emergency department . Clin Infect Dis . 2017 ; 65 ( 4 ) : 675 – 9 . 13 . Eifan SA , Nour I , Hanif A , Zamzam AMM , AlJohani SM . A pandemic risk assessment of Middle East respiratory syndrome coronavirus ( MERS - CoV ) in Saudi Arabia . Saudi J Biol Sci . 2017 ; 24 ( 7 ) : 1631 – 8 . 14 . Poletto C , Pelat C , Levy - Bruhl D , Yazdanpanah Y , Boelle PY , Colizza V . Assessment of the Middle East respiratory syndrome coronavirus ( MERS - CoV ) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach . Euro Surveill . 2014 ; 19 ( 23 ) 15 . Choi S , Jung E , Choi BY , Hur YJ , Ki M . High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks : mathematical modelling in Saudi Arabia and South Korea . J Hosp Infect . 2017 ; https : / / doi . org / 10 . 1016 / j . jhin . 2017 . 09 . 017 . 16 . Kim Y , Lee S , Chu C , Choe S , Hong S , Shin Y . The characteristics of middle eastern respiratory syndrome coronavirus transmission dynamics in South Korea . Osong Public Health Res Perspect . 2016 ; 7 ( 1 ) : 49 – 55 . 17 . Zhang XS , Pebody R , Charlett A , de Angelis D , Birrell P , Kang H , et al . Estimating and modelling the transmissibility of Middle East respiratory syndrome CoronaVirus during the 2015 outbreak in the Republic of Korea . Influenza Other Respir Viruses . 2017 ; 11 ( 5 ) : 434 – 44 . 18 . Chang HJ . Estimation of basic reproduction number of the Middle East respiratory syndrome coronavirus ( MERS - CoV ) during the outbreak in South Korea , 2015 . Biomed Eng Online . 2017 ; 16 ( 1 ) : 79 . 19 . Xia ZQ , Zhang J , Xue YK , Sun GQ , Jin Z . Modeling the transmission of Middle East respirator syndrome corona virus in the Republic of Korea . PLoS One . 2015 ; 10 ( 12 ) : e0144778 . 20 . Kim CJ , Choi WS , Jung Y , Kiem S , Seol HY , Woo HJ , et al . Surveillance of the Middle East respiratory syndrome ( MERS ) coronavirus ( CoV ) infection in healthcare workers after contact with confirmed MERS patients : incidence and risk factors of MERS - CoV seropositivity . Biomed Res Int . 2016 ; 22 ( 10 ) : 880 – 6 . 21 . El Bushra HE , Al Arbash HA , Mohammed M , Abdalla O , Abdallah MN , Al - Mayahi ZK , et al . Outcome of strict implementation of infection prevention control measures during an outbreak of Middle East respiratory syndrome . Am J Infect Control . 2017 ; 45 ( 5 ) : 502 – 7 . 22 . Drosten C , Meyer B , Muller MA , Corman VM , Al - Masri M , Hossain R , et al . Transmission of MERS - coronavirus in household contacts . N Engl J Med . 2014 ; 371 ( 9 ) : 828 – 35 . 23 . Park JW , Lee KJ , Lee KH , Lee SH , Cho JR , Mo JW , et al . Hospital outbreaks of Middle East respiratory syndrome , Daejeon , South Korea , 2015 . Emerg Infect Dis . 2017 ; 23 ( 6 ) : 898 – 905 . 24 . Park SH , Kim YS , Jung Y , Choi SY , Cho NH , Jeong HW , et al . Outbreaks of Middle East respiratory syndrome in two hospitals initiated by a single patient in Daejeon , South Korea . Infect Chemother . 2016 ; 48 ( 2 ) : 99 – 107 . 25 . Virlogeux V , Park M , Wu JT , Cowling BJ . Association between severity of MERS - CoV infection and incubation period . Emerg Infect Dis . 2016 ; 22 ( 3 ) : 526 – 8 . 26 . Cowling BJ , Park M , Fang VJ , Wu P , Leung GM , Wu JT . Preliminary epidemiological assessment of MERS - CoV outbreak in South Korea , May to June 2015 . Euro Surveill . 2015 ; 20 ( 25 ) : 7 – 13 . 27 . Ministry of Health and Welfare , Republic of Korea . MERS white book . 2016 . http : / / www . cdc . go . kr / CDC / intro / CdcKrIntro0101 . jsp ? menuIds = HOME001 - MNU1154 - MNU0005 - MNU0010 & cid = 70039 . Accessed 10 Oct 2017 . 28 . Park HY , Lee EJ , Ryu YW , Kim Y , Kim H , Lee H , et al . Epidemiological investigation of MERS - CoV spread in a single hospital in South Korea , May to June 2015 . Euro Surveill . 2015 ; 20 ( 25 ) : 1 – 6 . Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 14 of 15 29 . Sha J , Li Y , Chen X , Hu Y , Ren Y , Geng X , et al . Fatality risks for nosocomial outbreaks of Middle East respiratory syndrome coronavirus in the Middle East and South Korea . Arch Virol . 2017 ; 162 ( 1 ) : 33 – 44 . 30 . Liu M , Jiang C , Donovan C , Wen Y , Sun W . Middle East respiratory syndrome and medical students : letter from China . Int J Environ Res Public Health . 2015 ; 12 ( 10 ) : 13289 – 94 . 31 . Ahmed AE . Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia . Int J Infect Dis . 2017 ; 62 : 47 – 51 . 32 . Sherbini N , Iskandrani A , Kharaba A , Khalid G , Abduljawad M , Al - Jahdali H . Middle East respiratory syndrome coronavirus in Al - Madinah City , Saudi Arabia : demographic , clinical and survival data . J Epidemiolo Glob Health . 2017 ; 7 ( 1 ) : 29 – 36 . 33 . Halim AA , Alsayed B , Embarak S , Yaseen T , Dabbous S . Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients . Egypt J Chest Dis Tuberc . 2016 ; 65 ( 1 ) : 81 – 7 . 34 . Kim SW , Park JW , Jung HD , Yang JS , Park YS , Lee C , et al . Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea . Clin Infect Dis . 2017 ; 64 ( 5 ) : 551 – 7 . 35 . Mizumoto K , Saitoh M , Chowell G , Miyamatsu Y , Nishiura H . Estimating the risk of Middle East respiratory syndrome ( MERS ) death during the course of the outbreak in the Republic of Korea , 2015 . Int J Infect Dis . 2015 ; 39 : 7 – 9 . 36 . Assiri A , Abedi GR , Bin Saeed AA , Abdalla MA , al - Masry M , Choudhry AJ , et al . Multifacility outbreak of Middle East respiratory syndrome in Taif , Saudi Arabia . Emerg Infect Dis . 2016 ; 22 ( 1 ) : 32 – 40 . 37 . Noorwali AA , Turkistani AM , Asiri SI , Trabulsi FA , Alwafi OM , Alzahrani SH , et al . Descriptive epidemiology and characteristics of confirmed cases of Middle East respiratory syndrome coronavirus infection in the Makkah Region of Saudi Arabia , March to June 2014 . Ann Saudi Med . 2015 ; 35 ( 3 ) : 203 – 9 . 38 . Oboho IK , Tomczyk SM , Al - Asmari AM , Banjar AA , Al - Mugti H , Aloraini MS , et al . 2014 MERS - CoV outbreak in Jeddah – a link to health care facilities . N Engl J Med . 2015 ; 372 ( 9 ) : 846 – 54 . 39 . Lessler J , Salje H , Van Kerkhove MD , Ferguson NM , Cauchemez S , Rodriquez - Barraquer I , et al . Estimating the severity and subclinical burden of Middle East respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia . Am J Epidemiol . 2016 ; 183 ( 7 ) : 657 – 63 . 40 . Mohd HA , Memish ZA , Alfaraj SH , McClish D , Altuwaijri T , Alanazi MS , et al . Predictors of MERS - CoV infection : a large case control study of patients presenting with ILI at a MERS - CoV referral hospital in Saudi Arabia . Travel Med Infect Dis . 2016 ; 14 ( 5 ) : 464 – 70 . 41 . Penttinen PM , Kaasik - Aaslav K , Friaux A , Donachie A , Sudre B , Amato - Gauci AJ , et al . Taking stock of the first 133 MERS coronavirus cases globally – is the epidemic changing ? Euro Surveill . 2013 ; 18 ( 39 ) 42 . Alraddadi BM , Watson JT , Almarashi A , Abedi GR , Turkistani A , Sadran M , et al . Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans , Saudi Arabia , 2014 . Emerg Infect Dis . 2016 ; 22 ( 1 ) : 49 – 55 . 43 . Hastings DL , Tokars JI , Abdel Aziz IZ , Alkhaldi KZ , Bensadek AT , Alraddadi BM , et al . Outbreak of Middle East respiratory syndrome at tertiary care hospital , Jeddah , Saudi Arabia , 2014 . Emerg Infect Dis . 2016 ; 22 ( 5 ) : 794 – 801 . 44 . Kang CK , Song KH , Choe PG , Park WB , Bang JH , Kim ES , et al . Clinical and epidemiologic characteristics of spreaders of Middle East respiratory syndrome coronavirus during the 2015 outbreak in Korea . J Korean Med Sci . 2017 ; 32 ( 5 ) : 744 – 9 . 45 . Majumder MS , Brownstein JS , Finkelstein SN , Larson RC , Bourouiba L . Nosocomial amplification of MERS - coronavirus in South Korea , 2015 . Trans R Soc Trop Med Hyg . 2017 ; 111 ( 6 ) : 261 – 9 . 46 . Zhao J , Alshukairi AN , Baharoon SA , Ahmed WA , Bokhari AA , Nehdi AM , et al . Recovery from the Middle East respiratory syndrome is associated with antibody and T - cell responses . Sci Immunol . 2017 ; 2 ( 14 ) . 47 . Feikin DR , Alraddadi B , Qutub M , Shabouni O , Curns A , Oboho IK , et al . Association of higher MERS - CoV virus load with severe disease and death , Saudi Arabia , 2014 . Emerg Infect Dis . 2015 ; 21 ( 11 ) : 2029 – 35 . 48 . Ko J - H , Park GE , Lee JY , Lee JY , Cho SY , Ha YE , et al . Predictive factors for pneumonia development and progression to respiratory failure in MERS - CoV infected patients . J Inf Secur . 2016 ; 73 ( 5 ) : 468 – 75 . 49 . Saad M , Omrani AS , Baig K , Bahloul A , Elzein F , Matin MA , et al . Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection : a single - center experience in Saudi Arabia . Int J Infect Dis . 2014 ; 29 : 301 – 6 . 50 . Adegboye OA , Gayawan E , Hanna F . Spatial modelling of contribution of individual level risk factors for mortality from Middle East respiratory syndrome coronavirus in the Arabian Peninsula . PLoS One . 2017 ; 12 ( 7 ) : e0181215 . 51 . Ahmed AE . The predictors of 3 - and 30 - day mortality in 660 MERS - CoV patients . BMC Infect Dis . 2017 ; 17 ( 1 ) : 615 . 52 . Yang YM , Hsu CY , Lai CC , Yen MF , Wikramaratna PS , Chen HH , et al . Impact of comorbidity on fatality rate of patients with Middle East respiratory syndrome . Sci Rep . 2017 ; 7 ( 1 ) : 11307 . 53 . Alsahafi AJ , Cheng AC . The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia , 2012 - 2015 . Int J Infect Dis . 2016 ; 45 : 1 – 4 . 54 . Majumder MS , Kluberg SA , Mekaru SR , Brownstein JS . Mortality risk factors for Middle East respiratory syndrome outbreak , South Korea , 2015 . Emerg Infect Dis . 2015 ; 21 ( 11 ) : 2088 – 90 . 55 . Choi WS , Kang CI , Kim Y , Choi JP , Joh JS , Shin HS , et al . Clinical presentation and outcomes of Middle East respiratory syndrome in the Republic of Korea . Infect Chemother . 2016 ; 48 ( 2 ) : 118 – 26 . 56 . Nam H - S , Park JW , Ki M , Yeon M - Y , Kim J , Kim SW . High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon , the Republic of Korea . Int J Infect Dis . 2017 ; 58 : 37 – 42 . 57 . Almekhlafi GA , Albarrak MM , Mandourah Y , Hassan S , Alwan A , Abudayah A , et al . Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients . Crit Care . 2016 ; 20 ( 1 ) : 123 . 58 . Das KM , Lee EY , Al Jawder SE , Enani MA , Singh R , Skakni L , et al . Acute Middle East respiratory syndrome coronavirus : temporal lung changes observed on the chest radiographs of 55 patients . AJR Am J Roentgenol . 2015 ; 205 ( 3 ) : W267 – 74 . 59 . Al Ghamdi M , Alghamdi KM , Ghandoora Y , Alzahrani A , Salah F , Alsulami A , et al . Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus ( MERS CoV ) infection at a coronavirus referral center in the Kingdom of Saudi Arabia . BMC Infect Dis . 2016 ; 16 : 174 . 60 . Kim Y , Cheon S , Min CK , Sohn KM , Kang YJ , Cha YJ , et al . Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak . MBio . 2016 ; 7 ( 2 ) : e00019 . 61 . Kim DW , Kim YJ , Park SH , Yun MR , Yang JS , Kang HJ , et al . Variations in spike glycoprotein gene of MERS - CoV , South Korea , 2015 . Emerg Infect Dis . 2016 ; 22 ( 1 ) : 100 – 4 . 62 . Alqahtani AS , Wiley KE , Mushta SM , Yamazaki K , BinDhim NF , Heywood AE , et al . Association between Australian Hajj Pilgrims ' awareness of MERS - CoV , and their compliance with preventive measures and exposure to camels . J Travel Med . 2016 ; 23 ( 5 ) . https : / / doi . org / 10 . 1093 / jtm / taw046 . 63 . Choi J - S , Kim J - S . Factors influencing preventive behavior against Middle East respiratory syndrome - coronavirus among nursing students in South Korea . Nurse Educ Today . 2016 ; 40 : 168 – 72 . 64 . Kim JS , Choi JS . Middle East respiratory syndrome - related knowledge , preventive behaviours and risk perception among nursing students during outbreak . J Clin Nurs . 2016 ; 25 ( 17 – 18 ) : 2542 – 9 . 65 . Lee SS , Wong NS . Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea . Int J Infect Dis . 2015 ; 38 : 65 – 7 . 66 . Wong G , Liu W , Liu Y , Zhou B , Bi Y , Gao GF . MERS , SARS , and Ebola : the role of super - spreaders in infectious disease . Cell Host Microbe . 2015 ; 18 ( 4 ) : 398 – 401 . 67 . Stein RA . Super - spreaders in infectious diseases . Int J Infect Dis . 2011 ; 15 ( 8 ) : e510 – 3 . 68 . Matsuyama R , Nishiura H , Kutsuna S , Hayakawa K , Ohmagari N . Clinical determinants of the severity of Middle East respiratory syndrome ( MERS ) : a systematic review and meta - analysis . BMC Public Health . 2016 ; 16 ( 1 ) : 1203 . Park et al . BMC Public Health ( 2018 ) 18 : 574 Page 15 of 15